400-920-2911 sales@csnpharm.cn
您的位置 : 首页 / Metabolic Enzyme / Phospholipase / Darapladib/达普拉缔
CAS No.: 356057-34-6
Synonyms: SB-480848
Darapladib is a reversible lipoprotein-associated phospholipase A2 (Lp-PLA2) inhibitor with IC50 of 0.25 nM.
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00734032 | Atherosclerosis | Phase 2 | Completed | - | Japan ... more >> GSK Investigational Site Fukuoka, Japan, 812-0025 GSK Investigational Site Fukuoka, Japan, 818-0036 GSK Investigational Site Fukuoka, Japan, 819-1102 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 154-0024 GSK Investigational Site Tokyo, Japan, 160-0017 GSK Investigational Site Tokyo, Japan, 174-0051 Collapse << |
NCT01916720 | Atherosclerosis | Phase 2 | Completed | - | - |
NCT01067339 | Endothelial Dysfunction | Phase 3 | Completed | - | United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse << |
实验方案
技术信息
CAS号 | 356057-34-6 | 储存条件 |
|
|||||
分子式 | C36H38F4N4O2S | 运输 | 蓝冰 | |||||
分子量 | 666.77 | 别名 | SB-480848 | |||||
溶解度 |
|
动物实验配方 |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|
NCT00734032 | Atherosclerosis | Phase 2 | Completed | - | Japan ... more >> GSK Investigational Site Fukuoka, Japan, 812-0025 GSK Investigational Site Fukuoka, Japan, 818-0036 GSK Investigational Site Fukuoka, Japan, 819-1102 GSK Investigational Site Tokyo, Japan, 105-0004 GSK Investigational Site Tokyo, Japan, 154-0024 GSK Investigational Site Tokyo, Japan, 160-0017 GSK Investigational Site Tokyo, Japan, 174-0051 Collapse << |
NCT01916720 | Atherosclerosis | Phase 2 | Completed | - | - |
NCT01067339 | Endothelial Dysfunction | Phase 3 | Completed | - | United States, Minnesota ... more >> Mayo Clinic Rochester, Minnesota, United States, 55905 Collapse << |
NCT00734032 | - | - | Completed | - | - |
NCT01636271 | - | - | Completed | - | - |
NCT01067339 | - | - | Completed | - | - |
NCT01000727 | Acute Coronary Syndrome | Phase 3 | Completed | - | - |
NCT00743860 | Atherosclerosis | Phase 1 | Completed | - | United States, Washington ... more >> GSK Investigational Site Tacoma, Washington, United States, 98418 Collapse << |
NCT01000727 | - | - | Completed | - | - |
NCT00799903 | Atherosclerosis | Phase 3 | Completed | - | - |
NCT00411073 | Atherosclerosis | Phase 1 | Completed | - | United States, Indiana ... more >> GSK Investigational Site Evansville, Indiana, United States, 47714 Collapse << |
NCT00622830 | Atherosclerosis | Phase 1 | Completed | - | Japan ... more >> GSK Investigational Site Ibaraki, Japan, 305-0856 Collapse << |
NCT00799903 | - | - | Completed | - | - |
NCT01711723 | Atherosclerosis | Phase 1 | Completed | - | United States, Florida ... more >> GSK Investigational Site Orlando, Florida, United States, 32809 United States, Minnesota GSK Investigational Site Minneapolis, Minnesota, United States, 55404 Collapse << |
NCT01154114 | Atherosclerosis | Phase 1 | Completed | - | United States, Florida ... more >> GSK Investigational Site Miami, Florida, United States, 33143 GSK Investigational Site Orlando, Florida, United States, 32809 Collapse << |
NCT01506895 | Retinopathy, Diabetic | Phase 2 | Completed | - | Australia, New South Wales ... more >> GSK Investigational Site Parramatta, New South Wales, Australia, 2150 GSK Investigational Site Sydney, New South Wales, Australia, 2000 Australia, Victoria GSK Investigational Site East Melbourne, Victoria, Australia, 3002 Australia, Western Australia GSK Investigational Site Nedlands, Western Australia, Australia, 6009 Denmark GSK Investigational Site Glostrup, Denmark Germany GSK Investigational Site Freiburg, Baden-Wuerttemberg, Germany, 79106 GSK Investigational Site Ulm, Baden-Wuerttemberg, Germany, 89075 GSK Investigational Site Koeln, Nordrhein-Westfalen, Germany, 51109 GSK Investigational Site Muenster, Nordrhein-Westfalen, Germany, 48145 GSK Investigational Site Leipzig, Sachsen, Germany, 04103 Italy GSK Investigational Site Milano, Lombardia, Italy, 20132 GSK Investigational Site Milano, Lombardia, Italy, 20157 GSK Investigational Site Torino, Piemonte, Italy, 10122 GSK Investigational Site Padova, Veneto, Italy, 35128 Netherlands GSK Investigational Site Amsterdam, Netherlands, 1105 AZ GSK Investigational Site Rotterdam, Netherlands, 3011 BH Collapse << |
NCT00551317 | Atherosclerosis | Phase 1 | Completed | - | United States, Hawaii ... more >> GSK Investigational Site Honolulu, Hawaii, United States, 96813 Collapse << |
NCT01852565 | Atherosclerosis | Phase 1 | Completed | - | United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT00704431 | Atherosclerosis | Phase 1 | Completed | - | United States, Pennsylvania ... more >> GSK Investigational Site King of Prussia, Pennsylvania, United States, 19406 Collapse << |
NCT01751074 | Atherosclerosis | Phase 1 | Completed | - | United States, California ... more >> GSK Investigational Site Glendale, California, United States, 91206 Collapse << |
NCT01873339 | Atherosclerosis | Phase 1 | Completed | - | United States, Maryland ... more >> GSK Investigational Site Baltimore, Maryland, United States, 21225 Collapse << |
NCT02000804 | Atherosclerosis | Phase 1 | Completed | - | China ... more >> GSK Investigational Site Shanghai, China, 200030 Collapse << |
NCT02058641 | Atherosclerosis | Phase 1 | Completed | - | United Kingdom ... more >> GSK Investigational Site Cambridge, United Kingdom, CB2 0GG Collapse << |
联系我们
官方电话:400-920-2911
二维码
微信公众号 CSN官网